Thursday, February 16, 2017

Admission anticoagulants deadly

Medication from the group anticoagulants is not only useless in preventing strokes, but also dangerous for good health. Some people taking these medications are dying because of them, as British expert.


 Admission anticoagulants deadly  Anticoagulants


Medicines from the group anticoagulants   take millions people worldwide. These drugs thin the blood, do not let the form in it clots, which can turn into a deadly blood clots and cause stroke, deep vein thrombosis or pulmonary embolism. That is why these drugs so actively prescribed by doctors. Most often, these pills drunk middle- and older.


However, the known vascular surgeon from the UK Dr. Ander Cohen said anticoagulants On the contrary, increase the risk of stroke, but other type. If ischemic stroke occurs due order to thrombus shuts off blood flow to some parts of the brain (they account for 85% of all strokes), when hemorrhagic life-threatening situation arises due to cerebral hemorrhage. But anticoagulants contribute to this, as it does not give blood to clot. Their method also increases the risk of internal bleeding areas of the gastrointestinal tract.


Even 10-15 years ago, tens of thousands Russians died of a pulmonary embolism, deep vein thrombosis and ischemic strokes - all these diseases develop because of blood clots. Active use anticoagulants reduced the mortality rate is very noticeable. But, according to Dr. Cohen, drugs from this group is used too broadly. They can only be prescribed to those patients who are at high risk. Such well, who runs the risk of blood clots is not too much, or not at all is at risk, should not take anticoagulants. But many doctors prescribe them very well.


Each year in British hospitals for surgical treatment delivered two million patients, and 800 thousand receiving anticoagulants. According to Dr. Cohen, drugs give even 20% the remaining 1, 2 million, although there is no evidence that they need them. Criteria for discharge anticoagulants too blurred. (READ MORE)



Industry News

Go back to the main page

No comments:

Post a Comment